Suppression of ING1 expression in sporadic breast cancer

Oncogene

Volumn 18, Issue 37, 1999, Pages 5187-5193

  Toyama, Tatsuya ^a   Iwase, Hirotaka ^b   Watson, Peter ^c   Muzik, Huong ^a   Saettler, Elizabeth ^a   Magliocco, Anthony ^d   DiFrancesco, Lisa ^e   Forsyth, Peter ^a   Garkavtsev, Igor ^a,f   Kobayashi, Shunzo ^b   Riabowol, Karl ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^c UNIVERSITY OF MANITOBA   (Canada)

^d UNIVERSITY OF SASKATCHEWAN   (Canada)

^e FOOTHILLS HOSPITAL   (Canada)

^f GENOME THERAPEUTICS CORPORATION   (United States)

Author keywords

Breast cancer; Expression; ING1; Mutation; SSCP; Tumour suppressor gene

Indexed keywords

MESSENGER RNA;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; GENE REPRESSION; GERM LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADULT; AMINO ACID SUBSTITUTION; BREAST NEOPLASMS; CANADA; CELL CYCLE PROTEINS; CODON; DISEASE PROGRESSION; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; IN SITU HYBRIDIZATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JAPAN; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM PROTEINS; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; POINT MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTEIN BIOSYNTHESIS; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0033575866     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202905     Document Type: Article

References (28)

1. Brenner A, Paladugu A, Wang H, Olopade O, Dreyling M and Aldaz C. (1996). Clin. Cancer Res., 2, 1993-1998.
2. Devilee P. Schuuring E, van de Vijver MJ and Cornelisse CJ. (1994). Crit. Rev. Oncog., 5, 247-270.
3. Diatchenko L, Lau Y-FC, Campbell AP, Chenchik A, Moqadam F, Huang B, Lukyanov S, Lukyanov K, Gurskaya N. Sverdlov ED and Siebert PD. (1996). Proc. Natl. Acad. Sci. USA, 93, 6025-6030.
4. Dobrovic A and Simpfendorfer D. (1997). Cancer Res., 57, 3347-3350.
5. Garkavtsev I, Boland D, Mai J, Wilson H, Veillette C and Riabowol K. (1997a). Hybridoma, 16, 537-540.
6. Garkavtsev I, Demetrick D and Riabowol K. (1997b). Cytogen. Cell Genet., 76, 176-178.
7. Garkavtsev I, Grigorian IA, Ossovskaya VS, Chernov MV, Chumakov PM and Gudkov AV. (1998). Nature, 391, 295-298.
8. Garkavtsev I, Kazarov A, Gudkov A and Riabowol K. (1996). Nature Genet., 14, 415-420.
9. Garkavtsev I and Riabowol K. (1997). Mol. Cell. Biol., 17, 2014-2019.
10. Harvey MB, Leco KJ, Arcellana-Panlilio MY, Zhang X, Edwards DR and Schultz GA. (1995). Development, 121, 1005-1014.
11. Helbing CC, Veillette C, Riabowol K, Johnston RN and Garkavtsev I. (1997). Cancer Res., 57, 1255-1258.
12. Herman J, Merlo A, Mao L, Lapidus R, Issa J, Davidson N, Sidransky D and Baylin S. (1995). Cancer Res., 55, 4525-4530.
13. Iwase H, Greenman JM, Barnes DM, Hodgson S, Bobrow L and Mathew CG. (1996). Cancer Lett., 108, 179-184.
14. Japanese Breast Cancer Society. (1992). General rules for clinical and pathological recording of breast cancer. Kanehara: Tokyo, pp. 1-14.
15. Leco KJ, Apte SS, Taniguchi GT, Hawkes SP, Khokha R, Schultz GA and Edwards DR. (1997). FEBS Letts., 401, 213-217.
16. Lisitsyn N, Lisitsyn N and Wigler M. (1993). Science, 259, 946-951.
17. Maestro R, Piccinin S, Doglioni C, Gasparotto D, Vukosavljevic T, Sulfaro S, Barzan L and Boiocchi M. (1996). Cancer Res., 56, 1146-1150.
18. Magdinier F, Ribieras S, Lenoir G, Frappart L and Dante R. (1998). Oncogene, 17, 3169-3176.
19. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB and Sidransky D. (1995). Nature Med., 1, 686-692.
20. Mostert MMC, van de Pol M, Olde Weghuis D, Suijkerbuijk RF, Geurts van Kessel AG, van Echten J, Oosterhuis JW and Looijenga LHJ. (1996). Cancer Genet. Cytogenet., 89, 146-152.
21. Motomura K, Nishisho I, Takai S, Tateishi H, Okazaki M, Yamamoto M, Miki T, Honjo T and Mori T. (1988). Genomics, 2, 180-184.
22. Rice J, Massey-Brown K and Futscher B. (1908). Oncogene, 17, 1807-1812.
23. Sourvinos G and Spandidos D. (1998). Biochem. Biophys. Res. Commun., 245, 75-80.
24. Thompson ME, Jensen RA, Obermiller PS, Page DL and Holt JT. (1995). Nature Genet., 9, 444-450.
25. Vidal-Puig A and Moller DE. (1994). Biotechniques, 17, 490-492.
26. Wong H, Anderson WD, Cheng T and Riabowol K. (1994). Anal. Biochem., 223, 251-258.
27. Yamashita H, Kobayashi S, Iwase H, Itoh Y, Kuzushima T, Iwata H, Itoh K, Naitoh A, Yamashita T, Masaoka A and Kimura N. (1993). Jpn. J. Cancer Res., 84, 871-878.
28. Yang-Feng TL, Li S, Han H and Schwartz PE. (1992). Int. J. Cancer, 52, 575-580.